An observational study in Mild Cognitive Impairment, sponsored by Power Life Sciences Inc.. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-01-17.
Sponsored by Power Life Sciences Inc. · Observational
Participation in medical research usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups.
This trial will admit a wide range of data on the clinical trial experience of mild cognitive impairment patients to determine which factors prevail in limiting a patient's ability to join or finish a trial.
It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future mild cognitive impairment patients.
3,842 studies on the registry are indexed under Cognitive Dysfunction; 1,099 are open to participants now.
This study's planned enrollment of 500 is above the median of 150 across 950 observational studies indexed under Cognitive Dysfunction.
Browse Cognitive Dysfunction studies →Power Life Sciences Inc. is the lead sponsor of 108 studies on the registry; 107 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Mild cognitive impairment patients who are actively considering participating in a clinical trial, but have not yet completed enrollment and randomization.
Exclusion Criteria:
Rate of patients who decide to enroll in a mild cognitive impairment clinical research.
Time frame: 3 months
Number of mild cognitive impairment study participants who remain in clinical study until completion.
Time frame: 12 months
Documents are hosted by the registry — open the source record to download them.
Plan to share: Undecided
This study is not yet recruiting, as verified in Jan 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Power Life Sciences Inc.